You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Plans are underway to add genomics data from various Danish cohorts to the browser, which will provide greater insight into disease progression.
Some are comparing iGenomics, a former high school intern's creation, to the fictional "medical tricorder" of "Star Trek" fame.
A team led by researchers at University College London studied mutations in almost 47,000 viral genomes collected from patients worldwide.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
The DrBioRight system goes beyond NLP to produce "natural-language understanding" through AI as it creates automated dialog with researchers to speed up data analysis.
Driving the shift is a belief that standard STR testing is not always a reliable tool for determining complex family relationships.
By employing distributed computational resources and a novel algorithm, the VariantSpark technology is able to process a trillion data points in 15 hours.
A computational method, coupled with PCR analysis and RNA-seq, helped researchers pinpoint several drugs that could be repurposed to fight COVID-19.
The findings underscore the value of carrying out large-scale human genetic analyses as part of drug target identification and validation efforts.
Researchers from startup Duality Technologies and Dana-Farber have demonstrated the efficacy and speed of a highly secure technique for analyzing encrypted genomic data.
Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.
According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.
In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.
Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.